semaglutide restrictions An Ongoing Crisis: Shortage Raises Dual Concerns for Obesity and Diabetes Treatment September 2, 2025: U.S. compounding

It supports arguments that the drug manufacturer should have developed a safer drug or disclosed the risk in warnings, labeling, or during marketing

LIPID FORMULATION DEVELOPMENT - Why Softgels Are the Technology of Choice Dipanwita De, PhD, and Kaspar van den Dries say solubility and bioavailability in OSD formulations remain major challenges within the early stages of drug development

These include: Orlistat : A lipase inhibitor that reduces fat absorption, with a different mechanism and side effect profile than appetite suppressants Naltrexone-bupropion : A combination medication affecting reward pathways and appetite regulation Phentermine-topiramate ER (Qsymia) : An FDA-approved combination that has been studied more extensively than phentermine-semaglutide and is approved for long-term use Tirzepatide (Zepbound) : A dual GIP/GLP-1 receptor agonist that has demonstrated greater weight loss than semaglutide in head-to-head clinical trials (SURMOUNT-5) Intensive lifestyle interventions remain foundational to successful weight management

She adds that when our mitochondria arent working well, it can contribute to fatigue and mood issues